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This study assessed the effect of antagonist conditioning contractions (ACC) on the 
subsequent force and electromyography of an agonist. Twelve subjects performed 
isokinetic elbow flexion on a dynamometer in 4 test conditions including a baseline 
condition without, and 1, 3 and 6 seconds after, isometric triceps extension. Average 
peak torque (T), peak torque/body weight (T:BW), average power (P), and rate of torque 
development (RTD) were assessed. Electromyographic data were obtained from elbow 
extensors and flexors. A repeated measures ANOVA with post hoc analysis 
demonstrated that T, T:BW, P, and RTD were higher in the baseline, compared to the 
post ACC conditions (P ≤ 0.05), and appears to be due to higher brachioradialis 
activation in the baseline condition in compared to some post ACC conditions (P ≤ 0.05).  
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INTRODUCTION: The activation of the antagonist in order to potentiate the agonist muscle 
group has been referred to as the successive induction and is thought to stimulate the Golgi 
tendon organ (GTO) (Kroll, 1972). The stimulation of the GTO in an antagonist, may inhibit 
its activation and stimulate the activation in a subsequently contracted agonist. In addition to 
successive induction, other similar terms for this process include the reversal of antagonists, 
which is present in the rapid transitions between antagonist and agonist muscle groups 
during movements such as walking, running, and rowing (Voss et al., 1985). Skilled athletes 
appear to be able to reduce antagonist co-activation as an adaptation that allows them to 
produce greater agonist force (Bazzucchi et al., 2008). 
In addition to successive induction and the reversal of antagonists, a small body of literature 
defines these phenomena as antagonist conditioning contractions (ACC). Research 
examining the role of ACC on agonist force demonstrates higher rates of force development 
but not higher peak force, and no evidence of increased muscle activation (Gabriel et al., 
2001; Grabiner et al., 1994; Kamimura et al., 2009).  Variations exist in the magnitude and 
duration of the antagonist activation which may affect the ergogenic potential of this 
stimulus. Furthermore, some evidence demonstrates that stimulating a muscle with a 
maximal or near maximal activation may potentiate rather than inhibit it (Robbins et al., 
2005) and efforts to reduce the activation of the antagonist via a fatiguing stimulus resulted 
in its potentiation and subsequent impairment of agonist functioning (Maynard and Ebben, 
2003).  Finally, some evidence indicates that the antagonist inhibition may last only 1 second 
(Chalmers, 2004). Thus, the challenge seems to be to activate the antagonist enough to 
stimulate the GTO, while not potentiating it, and to take advantage of the antagonist 
inhibition before it decays.  Therefore, the purpose of this study was to assess the duration 
of ACC on subsequent performance and activation of the agonist.  
 
METHODS: Twelve men (mean ± SD: age = 21.08 ± 1.80 years; height = 183.54 ± 8.88 cm; 
body mass = 83.39 ± 9.35 kg; frequency of resistance training = 3.25 ± 0.75 days/week) 
volunteered to serve as subjects for the study. Subjects signed an informed consent form 
prior to participating in the study which was approved by the Institutional Review Board.    
Subjects performed a general and dynamic warm up prior to the study.  Subjects then 
performed a task specific warm up on the dynamometer (System 4, Biodex Inc., Shirley, NY) 
consisting of  2 sets of 1 repetition of isometric (ISOM) elbow extension at 75 and 90% of 
their self perceived maximum ability and 2 sets of 2 repetitions of isokinetic (ISOK) elbow 
flexion at 75 and 90% of their self perceived maximum ability.  Subjects then rested for 5 
minutes and performed the test sets. 
Subjects performed 4 test sets in random order with 5 minutes of recovery between the sets. 
Tests sets included a baseline ISOK elbow flexion set without a preceding ACC set, and 3 
other test sets of ISOK elbow flexion occurring 1 second, 3 seconds, and 6 seconds after 
ISOM ACC elbow extension.  For each test set, kinetic and muscle activation data were 
collected using dynamometry and electromyography, respectively.   
For the test sets, subjects were positioned in the dynamometer according to manufacturer 
specifications. The system was calibrated with the system software. The right elbow was 
positioned goniometrically at a starting position of 10°of elbow flexion. Isometric ACC and 
ISOK elbow flexion was performed from this starting point. Isokinetic elbow flexion was 
performed at 60° per second through a range of motion of 120° of elbow flexion. The order 
of test sets was randomized with 5 minutes of recovery between tests to reduce order and 
fatigue effects.  
Torque curves for each subject were analyzed using manufacturer’s software.  Data were 
sampled for the entire range of motion of the ISOK test sets. Peak torque (T), torque to body 
weight ratio (T:BW), power (P), and rate of torque development (RTD) were calculated as 
the average of the two repetitions of each ISOK test sets.  Rate of torque development was 
calculated for the first 300 ms of each test exercise and normalized to a second.    
Electromyography was used to quantify muscle activity using a telemetered EMG system 
(Myomonitor IV, DelSys Inc. Boston, MA, USA).  The input impedance was 1015
All data were filtered with a 10-450 Hz band pass filter, saved, and analyzed with the use of 
software (EMGworks 3.1, DelSys Inc., Boston, MA, USA).  Root mean square signal 
processing was used and data were calculated using a 125 ms moving window. Root mean 
squared EMG data were analyzed for the muscle burst for ISOM ACC and the ISOK elbow 
flexion tests. Burst onset and offset was determined as the points at which the RMS EMG 
values initially exceeded and eventually fell below 150 percent of baseline EMG values for 
each muscle burst. Data were averaged for the two trials and normalized to a resting value 
for each muscle assessed.   
 Ohms with a 
common mode rejection ratio of >80 dB.  Electroymyographic data from the biceps brachii 
(BB) and brachioradialis (BR), were used to assess the agonist elbow flexors, consistent 
with previous work assessing ACC (Holt et al., 1969). Electromyographic data were also 
recorded from the triceps brachii-long head (TB-Long) and triceps brachii-lateral head (TB-
Lateral) in order to assess muscle activation of the antagonist during all test conditions.  
Data were recorded at a sampling rate of 1024 Hz using rectangular shaped (19.8 mm wide 
and 35 mm long) bipolar surface electrodes with 1 x 10 mm 99.9% Ag conductors, and an 
inter-conductor distance of 10 mm.  A common reference electrode was placed on the lateral 
malleolus of the right leg.  Skin preparation included shaving hair if necessary, abrasion, and 
cleaning the surface with alcohol.  Elastic tape was applied to secure electrode placement in 
order to minimize motion artifact and to provide strain relief for the electrode cables.  Surface 
electrodes were connected to an amplifier and streamed continuously through an analog to 
digital converter (DelSys Inc. Boston, MA, USA) to an IBM-compatible notebook computer.   
Data were analyzed with SPSS 16.0 using a repeated measures ANOVA and Bonferroni adjusted 
pairwise comparisons to identify the specific differences in T, T:BW, P, and RTD and RMS 
EMG for each muscle assessed between the test conditions. The criterion for significance was 
set at P ≤ 0.05. Effect sizes and power were determined ηp2
RESULTS: Statistical analysis revealed a significant main effect for T (P = 0.001, η
 and d, respectively.   
p² = 0.64, 
d = 1.00), T:BW (P ≤ 0.05, ηp² = 0.34, d = 0.92), P (P = 0.003, ηp² = 0.34, d = 0.92) and RTD 
(P ≤ 0.001, ηp² = 0.58, d = 1.00) demonstrating differences between the test conditions for 
these variables.  Table 1 shows the specific differences for these variables based on post 
hoc analysis. Statistical analysis of RMS EMG data revealed significant main effects for BB 
(P = 0.04, ηp² = 0.19, d = 0.54), BR (P = 0.04, ηp² = 0.23, d = 0.68), TB-long (P = 0.33), and 
TB-lateral (P = 0.72).  Table 2 shows the specific differences for these variables based on 
post hoc analysis. 
Table 1. Peak torque (T), torque to body weight ratio (T:BW), power (P), and rate of torque 
development (RTD) for isokinetic elbow flexion in baseline and 3 post ACC conditions.  
Condition T(N)*       T:BW(N)* P(w)** RTD(N∙sec-1)*  
Baseline (No ACC) 65.30  ± 12.26 81.06 ± 11.22 46.12 ± 11.72 154.60 ± 22.98 
1 sec post ACC 60.06  ± 10.39 73.88 ± 9.19 39.30 ± 8.73 130.49 ± 17.14 
3 sec post ACC 60.18  ± 10.19 73.67 ± 8.55 40.37 ± 8.66 124.14 ± 24.34 
6 sec post ACC 59.61  ± 10.33 73.39 ± 9.67 38.38 ± 9.29 132.73  ± 21.17 
*Baseline condition is significantly different than all ACC conditions (p ≤ 0.01). 
**Baseline condition is significantly different than all ACC conditions (p ≤ 0.05). 
  
Table 2. Muscle activation (millivolts) expressed as RMS EMG normalized to resting values for 
biceps brachii (BB), brachioradialis (BR), triceps brachii-long head (TB-long)  and triceps 
brachii-lateral head (TB-Lateral) in the baseline and 3 post ACC conditions.  
                                                    Antagonist                                                 Agonist 
Condition BB* BR**     TB-Long   TB-Lateral  
Baseline (No ACC) 0.803 ± 0.24   0.525 ± 0.11   0.032 ± 0.01 0.050 ± 0.02 
1 sec post ACC 0.816 ± 0.26  0.497 ± 0.09  0.031 ± 0.01 0.051 ± 0.02 
3 sec post ACC 0.785 ± 0.24  0.517 ± 0.11  0.033 ± 0.02 0.051 ± 0.02 
6 sec post ACC 0.837 ± 0.28  0.530 ± 0.12  0.033 ± 0.01 0.052 ± 0.03 
*3 second post ACC is significantly different than 6 seconds post ACC conditions (p ≤ 0.05). 
**Baseline condition is significantly different than 1 second post ACC; 1 second post ACC is 
significantly different than 6 seconds post ACC (p ≤ 0.05). 
 
DISCUSSION: This study demonstrates that MVIC ACC impaired subsequent agonist 
performance for all variables assessed, regardless of the duration of time after the ACC. 
This impairment appears to be due to higher levels of BR activation in the baseline condition 
compared to some of the conditions, following the ACC. Despite using brief and maximal 
ACC based on previous recommendations (Grabiner et al., 1994; Holt et al., 1969; 
Kamimura et al., 2009), no evidence of the inhibition of the antagonist was found. These 
results raise questions about the effectiveness activating the antagonist in order to augment 
performance in a subsequently activated agonist.  
Results of the present study differ from previous research examining the effect of ACC which 
demonstrated increased rate of force development (Gabriel et al., 2001; Grabiner et al., 
1994; Kamimura et al., 2009), but not force (Grabiner et al., 1994; Kamimura et al., 2009) or 
work (Grabiner et al., 1994).  
Most studies assessing ACC failed to find any increase in EMG of the agonist (Gabriel et al., 
2001; Holt et al., 1969; Kamimura et al., 2009) demonstrating that either EMG was unable to 
detect, or another mechanism was responsible for, the increase rate of force development 
demonstrated in these studies. In contrast, results of the present study show some 
differences in muscle activation of the agonist. However, these data demonstrate that the 
agonist is impaired, even when the agonist is activated only one second after the ACC. The 
present study also shows that there is no antagonist inhibition as assessed by EMG, 
regardless of time elapsed after the ACC. This finding is in contrast to the belief that the 
inhibition may only last one second (Chalmers, 2004), since in the present study, no 
antagonist inhibition was present at 1, 3 or 6 seconds post ACC. Thus, it is possible that any 
potential inhibition may last less that 1 second. If so, this limitation reduces the practical 
benefit of ACC for resistance training though does not mitigate the functional benefit of 
reversal of antagonists during a variety of functional movement that quickly transition 
between antagonist and agonist such as walking or running (Voss et al., 1985) or the 
potential for chronic adaptation in skilled performers (Bazzucchi et al., 2008). 
 
CONCLUSION: This study demonstrated that maximal short term ACC do not enhance, and 
appear to impair, kinetic performance and activation of prime movers in some conditions.  
No evidence of inhibition of the antagonist was found. These findings provide evidence that 
the use of ACC to enhance agonist performance may not be effective.  The activation of the 
antagonist shortly before the activation of an agonist muscle group during resistance training 
may have not be beneficial and may possibly be detrimental.  Thus, agonist/antagonist, push 
pull, and compound set resistance training strategies should be avoided in cases where 
maximum force development is desired. 
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